AVIEW LCS vs EchoSolv AS
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your primary need is a comprehensive, AI-driven platform for multi-modal cardiopulmonary assessment from low-dose CT scans. This tool is ideal for radiology departments and lung cancer screening programs requiring automated detection, quantification, and longitudinal comparison of lung nodules, emphysema, and coronary artery calcification. It streamlines workflows by providing integrated analysis and reporting for multiple conditions from a single scan.
View AVIEW LCS →Choose EchoSolv AS if…
Choose EchoSolv AS if your focus is on rapidly and accurately identifying patients at high risk for severe aortic stenosis based on echocardiogram measurements. This AI-powered clinical decision support tool is best suited for cardiology practices seeking to enhance diagnostic efficiency, provide second-reader support, and prioritize studies for closer review without requiring complex EMR integrations or image analysis. It offers ultra-fast risk detection to support timely clinical decisions.
View EchoSolv AS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | EchoSolv AS |
|---|---|---|
| Pricing | Subscription or one-off payment | Unknown |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS emphasizes a design that fits existing workflows without requiring EMR integration and utilizes measurement-based AI, which can simplify implementation and reduce friction in clinical settings. Its ultra-fast risk detection further contributes to a streamlined and efficient user experience for its specific decision support function.
Clinical Value
AVIEW LCSAVIEW LCS offers a broader clinical value by providing integrated, fully automatic analysis for multiple critical conditionsu2014lung cancer, COPD, and coronary artery calcificationu2014from a single low-dose CT scan. This comprehensive assessment enhances diagnostic accuracy across several significant disease areas, potentially leading to earlier and more holistic patient management.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, making it impossible to conduct a head-to-head comparison on cost-effectiveness or transparent pricing. While both offer significant clinical value in their respective domains, without specific pricing details, a definitive winner cannot be determined.
Enterprise Readiness
AVIEW LCSAVIEW LCS demonstrates superior enterprise readiness due to its extensive deployment options, including cloud-based, hybrid, locally on dedicated hardware, and locally virtualized solutions. This flexibility allows it to adapt to a wider range of enterprise IT infrastructures, security policies, and data residency requirements compared to EchoSolv AS's cloud-only deployment.
Innovation
AVIEW LCSAVIEW LCS showcases broader innovation by integrating fully automatic analysis for multiple distinct and clinically significant conditionsu2014lung cancer, COPD, and coronary artery calcificationu2014from a single CT scan. This multi-organ, multi-disease assessment represents a significant advancement in diagnostic efficiency and comprehensive patient risk assessment.
Support & Docs
TieNeither the provided structured facts nor readily available public information from web searches offer specific details regarding the level of support or documentation provided by either vendor. Both companies appear to follow a standard B2B model where such resources are typically provided directly to clients under contract, making a comparative assessment impossible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | EchoSolv AS |
|---|---|---|
| Name | AVIEW LCS | EchoSolv AS |
| Company | Coreline Soft Co. | Echo IQ |
| Description | AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows. | FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. |
| Tagline | AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment | Identify high-probability severe aortic stenosis (sAS) patients accurately, quickly, simply. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Oncology, Pulmonology, Radiology | Cardiology, Cardiothoracic Surgery |
| Key Features (Examples) | Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass), Automated comparison of nodules in follow-up CT scans, Comprehensive, automated report generation, Integration with PACS/RIS and third-party platforms | AI-powered clinical decision support for severe aortic stenosis probability, Consistent severe AS probability and guideline check from measurements, Second reader support to help prioritize studies for closer review, Real-world readiness; AI does not use LVOT measurements, Faster clinical review using standardized, measurement-based AI and guideline analysis, Measurement-based AI (analyzes numerical measurements, not images), Designed to fit existing workflows (no EMR integration required, integrates with PACS), Ultra-fast risk detection (under 3 seconds) |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and EchoSolv AS.